Table 5 Subsections highlighting potential barriers and facilitators to community pharmacist-administered injectable naltrexone for individuals who were formerly incarcerated

Chapter 46: Social services [37]

46.40(1)(a)

The department may distribute funds for community social, mental health, developmental disabilities, and alcohol and other drug abuse services.

46.47(1–3)

The department may award grants to provide nonnarcotic, non-addictive, injectable medically assisted treatment to a county that has a jail or drug court, provides care coordination for reentering inmates, and has identified how it will ensure all program participants are enrolled in Medical Assistance and will continue treatment upon reentry.

46.48(30)

The department may distribute grants to private nonprofit organizations for the provision of alcohol and other drug abuse treatment services in counties with a population of 750,000 or more. Treatment should only be provided to individuals who are eligible for federal temporary assistance for needy families.

46.975(2)

The department shall allocate funds to community-based organizations for providing drug abuse interventions and treatment directed at low-income Hispanics and Black Americans in urban areas, women, and youth.

Chapter 49: Public assistance and children and family services [38]

49.167(1)

The department may award grants private entities to provide community-based alcohol and other drug abuse treatment programs that are targeted at individuals who have a family income of not more than 200% of the poverty line and who are eligible for temporary assistance for needy families.

49.46(2)(bh)

The department shall provide reimbursement for services that are reimbursable under this section and that are provided by a licensed pharmacist within the scope of his or her license.

Chapter 51: State alcohol, drug abuse, developmental disabilities and mental health act [39]

51.4224(1)

“Opioid treatment system” means a structured delivery system for providing substance abuse prevention, intervention, or treatment services and 1) receives funds through the state under this chapter and 2) is approved by the state methadone authority.

51.423(1)

The department shall fund, within the limits of the department’s allocation for mental health services, services for mental illness, developmental disability, alcoholism, and drug abuse to meet standards of service quality and accessibility.

Chapter 153: Health care information [41]

153.87

The department of administration shall issue a request for proposals to establish and maintain an opioid and methamphetamine data system to collect, format, analyze, and disseminate information on opioid and methamphetamine use, which shall include (1) the number of opioid treatment centers in the state and (2) the number of persons who are incarcerated, on extended supervision or probation, or on parole and who are receiving naltrexone for extended-release in injectable suspension.

Chapter 450: Pharmacy examining board [43]

450.035(1)(r)

A pharmacist may not administer by injection a prescribed drug product or device unless he or she has successfully completed a course of study and training in administration technique conducted by a course provider approved by the Accreditation Council for Pharmacy Education or the board.

450.085(1)

An applicant for renewal of a license shall submit proof that he or she has completed, within the 2-year period immediately preceding the date of his or her application, 30 h of continuing education in courses conducted by a provider that is approved by the Accreditation Council for Pharmacy Education or in courses approved by the board.

Subsections of administrative code chapters

Chapter 105: Substance Abuse Screening, Testing and Treatment for Certain Department Work Experience Programs[46]

105.06(1–2)

Every individual who tests positive for the use of a controlled substance without presenting evidence of a valid prescription shall be required to participate in treatment in order to be eligible to participate in a work experience program. The administering agency shall provide information to every individual required to participate in controlled substance abuse treatment about treatment program providers.

Chapter 36: Comprehensive community services for persons with mental disorders and substance-use disorders [47]

36.10(2 g)

Each staff member (psychiatrists, physicians, psychologists, social workers, counselors, therapists, nurses, physician assistants, occupational therapists, peer specialist, and rehabilitation workers) shall have the interpersonal skills training and experience needed to perform the staff member’s assigned functions.

Chapter 66: Treatment Alternative Program [49]

66.01

The alcohol or other drug abuse (AODA) treatment alternative program (TAP) consists of grants made by the department to local agencies to provide TAP services, including assessment and treatment services, to persons likely to benefit from those services who are referred from courts, law enforcement agencies, probation and parole agents and other parts of the criminal justice system.

66.03(1)

To be eligible for a TAP grant an agency shall be certified to operate one or more AODA programs under Chapter DHS 75.

Chapter 75: Community Substance Use Services Standards [50]

75.12

All requirements in this chapter shall also be applicable to telehealth services delivered under this chapter.

75.18

A service shall have a service director, clinical supervisor, substance abuse counselor, prescribers, nurses, and mental health professionals.

75.59(1–2, 10)

“Opioid treatment program,” or “OTP,” means a service that provides for the management and rehabilitation of persons with an opioid use disorder through the use of FDA-approved medications. Additionally, OTPs shall provide adequate medical, counseling, vocational, educational, and other assessment and treatment services. For medical needs of a patient that exceed the scope of the service under this chapter, the service shall coordinate with appropriate medical providers.

Chapter 83: Community-based residential facilities [51]

83.37(2)(e)

Injectables, nebulizers, stomal and enteral medications, and medications, treatments or preparations delivered vaginally or rectally shall be administered by a registered nurse or by a licensed practical nurse within the scope of their license.

83.38(1)(k)

The CBRF shall provide or arrange transportation when needed for medical appointments, work, educational or training programs, religious services and for a reasonable number of community activities of interest.

Chapter 107: Covered services [52]

107.10(1)

Drugs and drug products covered by Medical Assistance (MA) include legend and non-legend drugs and supplies listed in the Wisconsin Medicaid drug index which are prescribed by a physician, dentist, optometrist, advanced practice nurse, or when a physician delegates the prescribing of drugs to a nurse practitioner or to a physician’s assistant.

Chapter 8: Employee Welfare Funds; Employee Benefit Plan Administrators; Small Employee Health Insurance [53]

8.72(16)

Each health benefit plan shall provide coverage for outpatient and transitional treatment for nervous and mental disorders and alcoholism and other drug abuse if medically necessary.

Chapter 7: Pharmacy practice [54]

7.13(1–4)

A pharmacist may administer a drug product or device and, after administration, notify the prescribing practitioner or enter the information in a patient record system shared by the prescribing practitioner. A pharmacist may not administer an injectable drug product or device unless they have completed a course of study and training in administration technique conducted by a course provider approved by the Accreditation Council for Pharmacy Education or the board.

Chapter 16: Continuing education for pharmacists [55]

16.02(1)

Each pharmacist shall sign a statement on the application for license renewal certifying that the pharmacist has completed at least 30 hours of acceptable continuing education programs within the 2-year period immediately preceding the date of his or her application for renewal.

16.03

The board recognizes only those educational programs offered by a provider approved by the Accreditation Council for Pharmacy Education at the time of attendance or other board approved programs.